![Richard C. Woodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard C. Woodman
Directeur/Membre du Conseil chez
H3 Biomedicine, Inc.
Profil
Richard C.
Woodman is currently the Director at H3 Biomedicine, Inc. He previously worked as the Senior Director-Medical at Johnson & Johnson from 2002 to 2006, and as the Head-US Oncology Clinical Development at Novartis, Inc. from 2006 to 2018.
He also served as the Chief Clinical Officer-Oncology Business Group at Eisai Co., Ltd. and as the Chief Medical Officer, SVP-Research & Development at Onconova Therapeutics, Inc. from 2018 to 2021.
Prior to his industry career, he was a Professor at the University of Calgary.
Woodman received his undergraduate degree from the University of British Columbia and his doctorate from the University of Calgary in 1981.
Postes actifs de Richard C. Woodman
| Sociétés | Poste | Début |
|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Directeur/Membre du Conseil | 11/01/2022 |
Anciens postes connus de Richard C. Woodman
| Sociétés | Poste | Fin |
|---|---|---|
| TRAWS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 15/01/2021 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/03/2018 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2006 |
| EISAI CO., LTD. | Corporate Officer/Principal | - |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Richard C. Woodman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Eisai Co., Ltd.
 Eisai Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development, manufacturing and sales of prescription and over-the-counter drugs | Commercial Services |
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Commercial Services |
